Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


Articles published in HIV Med

Retrieve available abstracts of 140 articles:
HTML format
Text format



Single Articles


    April 2017
  1. MARZEL A, Shilaih M, Turk T, Campbell NK, et al
    Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships.
    HIV Med. 2017 Apr 4. doi: 10.1111/hiv.12507.
    PubMed     Text format     Abstract available



  2. Abstracts of the 23rd Annual Conference of the British HIV Association (BHIVA), Liverpool, UK, 4-7 April 2017.
    HIV Med. 2017;18 Suppl 1:3-70.
    PubMed     Text format    


    March 2017
  3. JAMIESON L, Evans D, Brennan AT, Moyo F, et al
    Changes in elevated cholesterol in the era of tenofovir in South Africa: risk factors, clinical management and outcomes.
    HIV Med. 2017 Mar 23. doi: 10.1111/hiv.12495.
    PubMed     Text format     Abstract available


  4. TI L, Dong H, Kerr T, Turje RB, et al
    The effect of engagement in an HIV/AIDS integrated health programme on plasma HIV-1 RNA suppression among HIV-positive people who use illicit drugs: a marginal structural modelling analysis.
    HIV Med. 2017 Mar 19. doi: 10.1111/hiv.12493.
    PubMed     Text format     Abstract available


  5. ERB S, Letang E, Glass TR, Natamatungiro A, et al
    Health care provider communication training in rural Tanzania empowers HIV-infected patients on antiretroviral therapy to discuss adherence problems.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12499.
    PubMed     Text format     Abstract available


  6. MONROE AK, Zhang L, Jacobson LP, Plankey MW, et al
    The association between physical activity and cognition in men with and without HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12490.
    PubMed     Text format     Abstract available


  7. BROWN J, McGowan JA, Chouial H, Capocci S, et al
    Respiratory health status is impaired in UK HIV-positive adults with virologically suppressed HIV infection.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12497.
    PubMed     Text format     Abstract available


  8. SOCIAS ME, Ti L, Dong H, Shoveller J, et al
    High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
    HIV Med. 2017 Mar 13. doi: 10.1111/hiv.12501.
    PubMed     Text format     Abstract available


  9. GEBRESELASSIE HM, Kraus D, Fux CA, Haubitz S, et al
    Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study.
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12491.
    PubMed     Text format     Abstract available


  10. PAYNE B, Chadwick TJ, Blamire A, Anderson KN, et al
    Does efavirenz replacement improve neurological function in treated HIV infection?
    HIV Med. 2017 Mar 1. doi: 10.1111/hiv.12503.
    PubMed     Text format     Abstract available


    February 2017
  11. MENA A, Meijide H, Rodriguez-Osorio I, Castro A, et al
    Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12502.
    PubMed     Text format     Abstract available


  12. WANG Z, Wu X, Lau J, Mo P, et al
    Prevalence of and factors associated with unprotected anal intercourse with regular and nonregular male sexual partners among newly diagnosed HIV-positive men who have sex with men in China.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12500.
    PubMed     Text format     Abstract available


  13. PUHR R, Petoumenos K, Youds D, Law MG, et al
    The impact of changes in HIV management guidelines on time to treatment initiation in Australia.
    HIV Med. 2017 Feb 22. doi: 10.1111/hiv.12504.
    PubMed     Text format    


  14. RALLON N, Restrepo C, Vicario JL, Del Romero J, et al
    Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.
    HIV Med. 2017 Feb 20. doi: 10.1111/hiv.12494.
    PubMed     Text format     Abstract available


  15. WILLIAMS C
    Response to Glinka et al. "Timing matters - influenza vaccination to HIV-infected patients".
    HIV Med. 2017 Feb 16. doi: 10.1111/hiv.12485.
    PubMed     Text format    


  16. MANCINELLI S, Nielsen-Saines K, Germano P, Guidotti G, et al
    Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
    HIV Med. 2017 Feb 2. doi: 10.1111/hiv.12492.
    PubMed     Text format     Abstract available


  17. GALLIEN S, Journot V, Loriot MA, Sauvageon H, et al
    Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
    HIV Med. 2017 Feb 1. doi: 10.1111/hiv.12488.
    PubMed     Text format     Abstract available


    January 2017
  18. SERNA-OJEDA JC, Navas A, Graue-Hernandez EO
    Smaller needles, lower risks?: Occupational HIV risk for healthcare professionals.
    HIV Med. 2017 Jan 27. doi: 10.1111/hiv.12496.
    PubMed     Text format    


  19. DESAI S, Nardone A, Hughes G, Delpech V, et al
    HIV incidence in an open national cohort of men who have sex with men attending sexually transmitted infection clinics in England.
    HIV Med. 2017 Jan 27. doi: 10.1111/hiv.12498.
    PubMed     Text format     Abstract available


  20. ELLIOT ER, Singh S, Tyebally S, Gedela K, et al
    Recreational drug use and chemsex among HIV-infected in-patients: a unique screening opportunity.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12487.
    PubMed     Text format     Abstract available


  21. CRESSWELL FV, Levett T
    Specialist care of older adults with HIV infection in the UK: a service evaluation.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12481.
    PubMed     Text format     Abstract available


  22. DREW RS, Rice B, Ruutel K, Delpech V, et al
    HIV continuum of care in Europe and Central Asia.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12480.
    PubMed     Text format     Abstract available


  23. YOUSSEF E, Cooper V, Nixon E, Vera JH, et al
    The management of comorbidities in older people living with HIV in England: a cross sectional survey.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12484.
    PubMed     Text format    


  24. CALZA L, Colangeli V, Magistrelli E, Bussini L, et al
    Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12478.
    PubMed     Text format     Abstract available


  25. NUNEZ-TORRES R, Macias J, Rivero-Juarez A, Neukam K, et al
    Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12489.
    PubMed     Text format     Abstract available


  26. GLINKA ER, Smith DM, Johns ST
    Now is the Time to Study the Timing of Influenza Vaccine.
    HIV Med. 2017 Jan 24. doi: 10.1111/hiv.12486.
    PubMed     Text format    


  27. O'LAUGHLIN KN, Kasozi J, Rabideau DJ, Parker RA, et al
    The cascade of HIV care among refugees and nationals in Nakivale Refugee Settlement in Uganda.
    HIV Med. 2017 Jan 10. doi: 10.1111/hiv.12476.
    PubMed     Text format     Abstract available


  28. NOY M, Merika EE, Morar N, Nelson M, et al
    aSKINg advice-the need for specialist dermatologists in HIV units.
    HIV Med. 2017;18:64-65.
    PubMed     Text format    


  29. MADGE S, Smith C, Warren-Gash C, Bayly J, et al
    Screening for intimate partner violence in a London HIV clinic: characteristics of those screening positive.
    HIV Med. 2017;18:66-68.
    PubMed     Text format    


    December 2016
  30. SORIANO-ARANDES A, Noguera-Julian A, Fortuny C
    Impact of immigration on HIV mother-to-child transmission in Western Europe.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12482.
    PubMed     Text format    


  31. POVEDA E, Hernandez-Quero J, Perez-Elias MJ, Ribas MA, et al
    Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12479.
    PubMed     Text format     Abstract available


  32. HARRISON N, Poeppl W, Herkner H, Tillhof KD, et al
    Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey.
    HIV Med. 2016 Dec 30. doi: 10.1111/hiv.12483.
    PubMed     Text format     Abstract available


  33. SEWELL J, Daskalopoulou M, Nakagawa F, Lampe FC, et al
    Accuracy of self-report of HIV viral load among people with HIV on antiretroviral treatment.
    HIV Med. 2016 Dec 22. doi: 10.1111/hiv.12477.
    PubMed     Text format     Abstract available


  34. KUMAR P, Lakshmi YS, Kondapi AK
    An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12475.
    PubMed     Text format     Abstract available


  35. FLORIDIA M, Tamburrini E, Masuelli G, Martinelli P, et al
    Rate, correlates and outcomes of repeat pregnancy in HIV-infected women.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12473.
    PubMed     Text format     Abstract available


  36. CHADWICK DR, Hall C, Rae C, Rayment M, et al
    A feasibility study for a clinical decision support system prompting HIV testing.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12472.
    PubMed     Text format     Abstract available


  37. HENRIQUEZ-CAMACHO C, Villafuerte-Gutierrez P, Perez-Molina JA, Losa J, et al
    Opt-out screening strategy for HIV infection among patients attending emergency departments: systematic review and meta-analysis.
    HIV Med. 2016 Dec 21. doi: 10.1111/hiv.12474.
    PubMed     Text format     Abstract available


  38. JIN C, Cheng L, Hoxtermann S, Xie T, et al
    MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients.
    HIV Med. 2016 Dec 16. doi: 10.1111/hiv.12470.
    PubMed     Text format     Abstract available


  39. FRASER-TALIENTE T, Mackie NE, Kaye S, Nyirenda M, et al
    Off-licence use of once-daily maraviroc in children and adolescents with perinatally acquired HIV-1 infection.
    HIV Med. 2016 Dec 16. doi: 10.1111/hiv.12467.
    PubMed     Text format    


    November 2016
  40. MACIAS J, Monge P, Mancebo M, Merchante N, et al
    High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.
    HIV Med. 2016 Nov 24. doi: 10.1111/hiv.12471.
    PubMed     Text format     Abstract available


  41. TOWNSEND CL, de Ruiter A, Peters H, Nelson-Piercy C, et al
    Pregnancies in older women living with HIV in the UK and Ireland.
    HIV Med. 2016 Nov 16. doi: 10.1111/hiv.12469.
    PubMed     Text format     Abstract available


  42. HOFFMANN C, Welz T, Sabranski M, Kolb M, et al
    Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.
    HIV Med. 2016 Nov 10. doi: 10.1111/hiv.12468.
    PubMed     Text format     Abstract available


  43. WEBEL AR, Sattar A, Funderburg NT, Kinley B, et al
    Alcohol and dietary factors associate with gut integrity and inflammation in HIV-infected adults.
    HIV Med. 2016 Nov 9. doi: 10.1111/hiv.12442.
    PubMed     Text format     Abstract available



  44. A note of thanks to referees for Volume 17, 2016.
    HIV Med. 2016;17:778-780.
    PubMed     Text format    



  45. Erratum.
    HIV Med. 2016;17:781.
    PubMed     Text format    


    October 2016
  46. UNDERWOOD J, De Francesco D, Post FA, Vera JH, et al
    Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIV.
    HIV Med. 2016 Oct 26. doi: 10.1111/hiv.12434.
    PubMed     Text format     Abstract available


  47. GRINT D, Tedaldi E, Peters L, Mocroft A, et al
    Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals.
    HIV Med. 2016 Oct 26. doi: 10.1111/hiv.12466.
    PubMed     Text format     Abstract available


  48. FERRAIOLI G
    The clinical value of the controlled attenuation parameter in the follow-up of HIV-infected patients.
    HIV Med. 2016 Oct 4. doi: 10.1111/hiv.12443.
    PubMed     Text format    


  49. ST-JEAN M, Harrigan PR, Sereda P, Montaner J, et al
    An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
    HIV Med. 2016 Oct 4. doi: 10.1111/hiv.12435.
    PubMed     Text format     Abstract available


  50. MODY N, Nixon E, Buckingham T, Churchill D, et al
    It's the quality that counts: audit of the quality of transfer information for patients moving their HIV care between units.
    HIV Med. 2016;17:708.
    PubMed     Text format    


  51. RAFFI F, Esser S, Nunnari G, Perez-Valero I, et al
    Switching regimens in virologically suppressed HIV-1-infected patients: evidence base and rationale for integrase strand transfer inhibitor (INSTI)-containing regimens.
    HIV Med. 2016;17 Suppl 5:3-16.
    PubMed     Text format     Abstract available


    September 2016
  52. CANAN CE, Lau B, McCaul ME, Keruly J, et al
    Effect of alcohol consumption on all-cause and liver-related mortality among HIV-infected individuals.
    HIV Med. 2016 Sep 28. doi: 10.1111/hiv.12433.
    PubMed     Text format     Abstract available


  53. LENG CY, Low HC, Chua LL, Chong ML, et al
    Human papillomavirus 16 (HPV16) and HPV52 E6-specific immunity in HIV-infected adults on combination antiretroviral therapy.
    HIV Med. 2016 Sep 20. doi: 10.1111/hiv.12432.
    PubMed     Text format     Abstract available


  54. FEUILLET P, Lert F, Tron L, Aubriere C, et al
    Prevalence of and factors associated with depression among people living with HIV in France.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12438.
    PubMed     Text format     Abstract available


  55. JUDD A, Lodwick R, Noguera-Julian A, Gibb DM, et al
    Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12411.
    PubMed     Text format     Abstract available


  56. BOUTELOUP V, Sabin C, Mocroft A, Gras L, et al
    Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naive patients.
    HIV Med. 2016 Sep 14. doi: 10.1111/hiv.12389.
    PubMed     Text format     Abstract available


  57. ZHONG F, Tang W, Cheng W, Lin P, et al
    Acceptability and feasibility of a social entrepreneurship testing model to promote HIV self-testing and linkage to care among men who have sex with men.
    HIV Med. 2016 Sep 7. doi: 10.1111/hiv.12437.
    PubMed     Text format     Abstract available


  58. MODY N, Perry N, Richardson D, Barbour L, et al
    Routine HIV testing in acute hospital admissions.
    HIV Med. 2016;17:634.
    PubMed     Text format    


    August 2016
  59. TEERAANANCHAI S, Kerr SJ, Amin J, Ruxrungtham K, et al
    Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis.
    HIV Med. 2016 Aug 31. doi: 10.1111/hiv.12421.
    PubMed     Text format     Abstract available


  60. KOWALSKA JD, Oprea C, de Witt S, Pozniak A, et al
    Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12436.
    PubMed     Text format     Abstract available


  61. NADEL J, Holloway CJ
    Screening and risk assessment for coronary artery disease in HIV infection: an unmet need.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12422.
    PubMed     Text format     Abstract available


  62. ZHANG X, Tang W, Li Y, Mahapatra T, et al
    The HIV/AIDS epidemic among young people in China between 2005 and 2012: results of a spatial temporal analysis.
    HIV Med. 2016 Aug 24. doi: 10.1111/hiv.12408.
    PubMed     Text format     Abstract available


  63. GISSLEN M, Svedhem V, Lindborg L, Flamholc L, et al
    Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 continuum of HIV care targets.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12431.
    PubMed     Text format     Abstract available


  64. LORD E, Stockdale AJ, Malek R, Rae C, et al
    Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12430.
    PubMed     Text format     Abstract available


  65. HOWARTH AR, Burns FM, Apea V, Jose S, et al
    Development and application of a new measure of engagement in out-patient HIV care.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12427.
    PubMed     Text format     Abstract available


  66. KHADEMI N, Reshadat S, Zangeneh A, Saeidi S, et al
    A comparative study of the spatial distribution of HIV prevalence in the metropolis of Kermanshah, Iran, in 1996-2014 using geographical information systems.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12416.
    PubMed     Text format     Abstract available


  67. SILVA-PINTO A, Costa A, Serrao R, Sarmento A, et al
    Ischaemic stroke in HIV-infected patients: a case-control study.
    HIV Med. 2016 Aug 18. doi: 10.1111/hiv.12415.
    PubMed     Text format     Abstract available


  68. FLOWERS P, Riddell J, Park C, Ahmed B, et al
    Preparedness for use of the rapid result HIV self-test by gay men and other men who have sex with men (MSM): a mixed methods exploratory study among MSM and those involved in HIV prevention and care.
    HIV Med. 2016 Aug 5. doi: 10.1111/hiv.12420.
    PubMed     Text format     Abstract available


  69. DO TC, Boettiger D, Law M, Pujari S, et al
    Smoking and projected cardiovascular risk in an HIV-positive Asian regional cohort.
    HIV Med. 2016;17:542-9.
    PubMed     Text format     Abstract available


  70. TOMINSKI D, Katchanov J, Driesch D, Daley MB, et al
    The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12403.
    PubMed     Text format     Abstract available


  71. LIN SY, Lachowsky NJ, Hull M, Rich A, et al
    Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12369.
    PubMed     Text format     Abstract available


  72. MILAZZO L, Lai A, Calvi E, Ronzi P, et al
    Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12429.
    PubMed     Text format     Abstract available


  73. KRIKKE M, Arends JE, Van Lelyveld S, Hoepelman A, et al
    Greater carotid intima media thickness at a younger age in HIV-infected patients compared with reference values for an uninfected cohort.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12428.
    PubMed     Text format     Abstract available


  74. ROJAS CASTRO D, Quatremere G, Sagaon-Teyssier L, Le Gall JM, et al
    Informal pre-exposure prophylaxis use in France: results from the Flash PrEP survey (2014).
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12419.
    PubMed     Text format    


  75. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12418.
    PubMed     Text format     Abstract available


  76. IMAZ A, Niubo J, Kashuba AD, Ferrer E, et al
    Elvitegravir concentrations in seminal plasma in HIV-1-infected men.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12417.
    PubMed     Text format     Abstract available


  77. TOSTEVIN A, White E, Dunn D, Croxford S, et al
    Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12414.
    PubMed     Text format     Abstract available


  78. TEIRA R, Vidal F, Munoz-Sanchez P, Geijo P, et al
    Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12413.
    PubMed     Text format     Abstract available


  79. FRENCH CE, Thorne C, Byrne L, Cortina-Borja M, et al
    Presentation for care and antenatal management of HIV in the UK, 2009-2014.
    HIV Med. 2016 Aug 1. doi: 10.1111/hiv.12410.
    PubMed     Text format     Abstract available


  80. CHURCHILL D, Waters L, Ahmed N, Angus B, et al
    British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015.
    HIV Med. 2016;17 Suppl 4:s2-s104.
    PubMed     Text format    


  81. GERETTI AM, Brook G, Cameron C, Chadwick D, et al
    British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.
    HIV Med. 2016;17 Suppl 3:s2-s81.
    PubMed     Text format    


    July 2016
  82. MCGOWAN JA, Sherr L, Rodger AJ, Fisher M, et al
    Age, time living with diagnosed HIV infection, and self-rated health.
    HIV Med. 2016 Jul 7. doi: 10.1111/hiv.12398.
    PubMed     Text format     Abstract available


  83. KESSELRING S, Cescon A, Colley G, Osborne C, et al
    Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12409.
    PubMed     Text format     Abstract available


  84. FOSTER C, Bamford A, Turkova A, Welch S, et al
    Paediatric European Network for Treatment of AIDS Treatment Guideline 2016 update: antiretroviral therapy recommended for all children living with HIV.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12399.
    PubMed     Text format    


  85. POST FA, Yombi JC, Hougardy JM
    Monitoring of kidney function in older people living with HIV.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12396.
    PubMed     Text format    


  86. MUSSO CG, Belloso WH
    Monitoring of kidney function in elderly HIV-positive patients.
    HIV Med. 2016 Jul 6. doi: 10.1111/hiv.12395.
    PubMed     Text format    


    June 2016
  87. HERNANDEZ AV, Thota P, Pellegrino D, Pasupuleti V, et al
    A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12402.
    PubMed     Text format     Abstract available


  88. ROSSOUW TM, Nieuwoudt M, Manasa J, Malherbe G, et al
    HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12400.
    PubMed     Text format     Abstract available


  89. MYER L, Phillips TK, McIntyre JA, Hsiao NY, et al
    HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12397.
    PubMed     Text format     Abstract available


  90. ARMENIA D, Di Carlo D, Maffongelli G, Borghi V, et al
    Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
    HIV Med. 2016 Jun 28. doi: 10.1111/hiv.12388.
    PubMed     Text format     Abstract available


  91. LI M, Foli Y, Liu Z, Wang G, et al
    High frequency of mitochondrial DNA mutations in HIV-infected treatment-experienced individuals.
    HIV Med. 2016 Jun 22. doi: 10.1111/hiv.12390.
    PubMed     Text format     Abstract available


  92. GIRARD PM, Antinori A, Arribas JR, Ripamonti D, et al
    Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12386.
    PubMed     Text format     Abstract available


  93. CHEUNG CC, Ding E, Sereda P, Yip B, et al
    Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12379.
    PubMed     Text format     Abstract available


  94. SANCHEZ-GONZALEZ G
    The cost-effectiveness of treating triple coinfection with HIV, tuberculosis and hepatitis C virus.
    HIV Med. 2016 Jun 9. doi: 10.1111/hiv.12372.
    PubMed     Text format     Abstract available


  95. VIDELA S, Sirera G, Ornelas A, Pinol M, et al
    Incidence of squamous intraepithelial lesions in the anal canal of HIV-infected men with normal cytology, up to 8 years of follow-up.
    HIV Med. 2016;17:479-81.
    PubMed     Text format    


    May 2016
  96. CRAUWELS HM, Kakuda TN, Ryan B, Zorrilla C, et al
    Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12366.
    PubMed     Text format     Abstract available


  97. SHMAGEL KV, Saidakova EV, Shmagel NG, Korolevskaya LB, et al
    Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12357.
    PubMed     Text format     Abstract available


  98. MICHEL L, Lions C, Winnock M, Lang JP, et al
    Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) HEPAVIH CO13 cohort].
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12382.
    PubMed     Text format     Abstract available


  99. RODKJAER L, Gabel C, Laursen T, Slot M, et al
    Simple and practical screening approach to identify HIV-infected individuals with depression or at risk of developing depression.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12381.
    PubMed     Text format     Abstract available


  100. SELLIER P, Ostertag A, Collet C, Trout H, et al
    Disrupted trabecular bone micro-architecture in middle-aged male HIV-infected treated patients.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12380.
    PubMed     Text format     Abstract available


  101. EDELMAN EJ, Gordon KS, Tate JP, Becker WC, et al
    The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.
    HIV Med. 2016 May 17. doi: 10.1111/hiv.12377.
    PubMed     Text format     Abstract available


  102. SIMMONS R, Kall M, Collins S, Cairns G, et al
    A global survey of HIV-positive people's attitudes towards cure research.
    HIV Med. 2016 May 11. doi: 10.1111/hiv.12391.
    PubMed     Text format     Abstract available


  103. FATKENHEUER G, Jessen H, Stoehr A, Jung N, et al
    PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.
    HIV Med. 2016 May 11. doi: 10.1111/hiv.12363.
    PubMed     Text format     Abstract available


  104. PASTORI D, Esposito A, Carnevale R, Bartimoccia S, et al
    Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F in HIV-1 patients on abacavir-based therapies.
    HIV Med. 2016 May 10. doi: 10.1111/hiv.12383.
    PubMed     Text format     Abstract available


  105. MUTIMURA E, Shi Q, Hoover DR, Anastos K, et al
    Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naive HIV-positive and HIV-negative Rwandan women.
    HIV Med. 2016 May 10. doi: 10.1111/hiv.12376.
    PubMed     Text format     Abstract available


  106. GAZZARD B
    Editorial.
    HIV Med. 2016;17 Suppl 2:3.
    PubMed     Text format    


  107. FLANDRE P, Pugliese P, Allavena C, Katlama C, et al
    Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.
    HIV Med. 2016;17:380-4.
    PubMed     Text format     Abstract available


  108. ROJAS J, Lonca M, Imaz A, Estrada V, et al
    Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir.
    HIV Med. 2016;17:340-9.
    PubMed     Text format     Abstract available


  109. FIRLAG-BURKACKA E, Swiecki P, Cielniak I, Siwak E, et al
    High frequency of neurosyphilis in HIV-positive patients diagnosed with early syphilis.
    HIV Med. 2016;17:323-6.
    PubMed     Text format     Abstract available


    April 2016
  110. TUGUME L, Morawski BM, Abassi M, Bahr NC, et al
    Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.
    HIV Med. 2016 Apr 28. doi: 10.1111/hiv.12387.
    PubMed     Text format     Abstract available


  111. LIEDTKE MD, Tomlin CR, Skrepnek GH, Farmer KC, et al
    HIV Pharmacist's Impact on Inpatient Antiretroviral Errors.
    HIV Med. 2016 Apr 1. doi: 10.1111/hiv.12375.
    PubMed     Text format     Abstract available



  112. Abstracts of the 22nd Annual Conference of the British HIV Association (BHIVA), Manchester, UK, 19-22 April 2016.
    HIV Med. 2016;17 Suppl 1:3-71.
    PubMed     Text format    


    March 2016
  113. MACIAS J, Real LM, Rivero-Juarez A, Merchante N, et al
    Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients.
    HIV Med. 2016 Mar 29. doi: 10.1111/hiv.12384.
    PubMed     Text format     Abstract available


  114. ERLANDSON KM, Plankey MW, Springer G, Cohen HS, et al
    Fall frequency and associated factors among men and women with or at risk for HIV infection.
    HIV Med. 2016 Mar 29. doi: 10.1111/hiv.12378.
    PubMed     Text format     Abstract available


  115. CALZA L, Colangeli V, Magistrelli E, Manfredi R, et al
    No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy.
    HIV Med. 2016 Mar 29. doi: 10.1111/hiv.12374.
    PubMed     Text format     Abstract available


  116. MULHALL BP, Wright ST, De La Mata N, Allen D, et al
    Risk factors associated with incident sexually transmitted infections in HIV-positive patients in the Australian HIV Observational Database: a prospective cohort study.
    HIV Med. 2016 Mar 28. doi: 10.1111/hiv.12371.
    PubMed     Text format     Abstract available


  117. VELEN K, Charalambous S, Innes C, Churchyard GJ, et al
    Chronic hepatitis B increases mortality and complexity among HIV-coinfected patients in South Africa: a cohort study.
    HIV Med. 2016 Mar 17. doi: 10.1111/hiv.12367.
    PubMed     Text format     Abstract available


  118. BADER J, Schoni-Affolter F, Boni J, Gorgievski-Hrisoho M, et al
    Correlating HIV tropism with immunological response under combination antiretroviral therapy.
    HIV Med. 2016 Mar 17. doi: 10.1111/hiv.12365.
    PubMed     Text format     Abstract available


  119. MCDAID LM, Aghaizu A, Frankis J, Riddell J, et al
    Frequency of HIV testing among gay and bisexual men in the UK: implications for HIV prevention.
    HIV Med. 2016 Mar 15. doi: 10.1111/hiv.12373.
    PubMed     Text format     Abstract available


  120. LEE FJ, Monteiro P, Baker D, Bloch M, et al
    Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial.
    HIV Med. 2016 Mar 14. doi: 10.1111/hiv.12362.
    PubMed     Text format     Abstract available


  121. ANTELA A, Aguiar C, Compston J, Hendry BM, et al
    The role of tenofovir alafenamide (TAF) in future HIV management.
    HIV Med. 2016 Mar 8. doi: 10.1111/hiv.12401.
    PubMed     Text format     Abstract available


  122. ESTRADA V, Monge S, Gomez-Garre MD, Sobrino P, et al
    Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.
    HIV Med. 2016 Mar 3. doi: 10.1111/hiv.12368.
    PubMed     Text format     Abstract available


  123. ORKIN C, Flanagan S, Wallis E, Ireland G, et al
    Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaign.
    HIV Med. 2016;17:222-30.
    PubMed     Text format     Abstract available


    February 2016
  124. SHEPHERD L, Borges A, Ledergerber B, Domingo P, et al
    Infection-related and -unrelated malignancies, HIV and the aging population.
    HIV Med. 2016 Feb 18. doi: 10.1111/hiv.12359.
    PubMed     Text format     Abstract available


  125. SADLIER C, Sheils O, Bergin C
    Response to letter: limitations of human papillomavirus DNA testing in measuring previous exposure and vaccine protection.
    HIV Med. 2016 Feb 9. doi: 10.1111/hiv.12353.
    PubMed     Text format    


  126. ROKX C, Gras L, van de Vijver D, Verbon A, et al
    Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naive HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort.
    HIV Med. 2016 Feb 4. doi: 10.1111/hiv.12355.
    PubMed     Text format     Abstract available


    January 2016
  127. GLINKA ER, Smith DM, Johns ST
    Timing Matters - Influenza Vaccination to HIV-Infected Patients.
    HIV Med. 2016 Jan 26. doi: 10.1111/hiv.12360.
    PubMed     Text format     Abstract available


  128. COLLAZOS J, Valle-Garay E, Carton JA, Montes AH, et al
    Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy.
    HIV Med. 2016 Jan 11. doi: 10.1111/hiv.12354.
    PubMed     Text format     Abstract available


    December 2015
  129. ARRIBAS JR, Girard PM, Paton N, Winston A, et al
    Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials.
    HIV Med. 2015 Dec 28. doi: 10.1111/hiv.12348.
    PubMed     Text format     Abstract available


  130. BURGOS J, Curran A, Landolfi S, Navarro J, et al
    The effectiveness of electrocautery ablation for the treatment of high-grade anal intraepithelial neoplasia in HIV-infected men who have sex with men.
    HIV Med. 2015 Dec 21. doi: 10.1111/hiv.12352.
    PubMed     Text format     Abstract available


  131. MORENO-PEREZ O, Boix V, Merino E, Pico A, et al
    Biological markers of fertility (inhibin-B) in HIV-infected men: influence of HIV infection and antiretroviral therapy.
    HIV Med. 2015 Dec 21. doi: 10.1111/hiv.12350.
    PubMed     Text format     Abstract available


  132. ROTZINGER A, Locatelli I, Bugnon O, Fayet Mello A, et al
    Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management.
    HIV Med. 2015 Dec 21. doi: 10.1111/hiv.12345.
    PubMed     Text format     Abstract available


  133. WILKINS E, Fisher M, Brogan AJ, Talbird SE, et al
    Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naive adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial
    HIV Med. 2015 Dec 9. doi: 10.1111/hiv.12349.
    PubMed     Text format     Abstract available


  134. LABOUNTY TM, Hardy WD, Fan Z, Yumul R, et al
    Carotid artery thickness is associated with chronic use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus: A 3.0 Tesla magnetic resonance imaging study.
    HIV Med. 2015 Dec 3. doi: 10.1111/hiv.12351.
    PubMed     Text format     Abstract available


    November 2015
  135. LAMBERT CT, Sandesara PB, Hirsh B, Shaw LJ, et al
    HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
    HIV Med. 2015 Nov 26. doi: 10.1111/hiv.12346.
    PubMed     Text format     Abstract available


  136. WINSTON A, Stohr W, Antinori A, Arenas-Pinto A, et al
    Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
    HIV Med. 2015 Nov 26. doi: 10.1111/hiv.12344.
    PubMed     Text format     Abstract available


  137. BRANNSTROM J, Svedhem Johansson V, Marrone G, Wendahl S, et al
    Deficiencies in the health care system contribute to a high rate of late HIV diagnosis in Sweden.
    HIV Med. 2015 Nov 11. doi: 10.1111/hiv.12321.
    PubMed     Text format     Abstract available


  138. RYOM L, Boesecke C, Gisler V, Manzardo C, et al
    Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons.
    HIV Med. 2015 Nov 8. doi: 10.1111/hiv.12322.
    PubMed     Text format     Abstract available


  139. MCKINNON E, Castley A, Payne L, Pummer S, et al
    Determinants of residual viraemia during combination HIV treatment: Impacts of baseline HIV RNA levels and treatment choice.
    HIV Med. 2015 Nov 4. doi: 10.1111/hiv.12323.
    PubMed     Text format     Abstract available


    September 2015
  140. ROUGEMONT M, Nchotu Ngang P, Stoll B, Delhumeau C, et al
    Safety of zidovudine dose reduction in treatment-naive HIV infected patients. A randomized controlled study (MiniZID).
    HIV Med. 2015 Sep 10. doi: 10.1111/hiv.12303.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: